moxisylyte has been researched along with Tremor in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mai, J | 1 |
| Olsen, RB | 1 |
| Abila, B | 1 |
| Wilson, JF | 1 |
| Marshall, RW | 1 |
| Richens, A | 1 |
2 other studies available for moxisylyte and Tremor
| Article | Year |
|---|---|
Depression of essential tremor by alpha-adrenergic blockade.
Topics: Humans; Moxisylyte; Parkinson Disease; Tremor | 1981 |
Differential effects of alpha-adrenoceptor blockade on essential, physiological and isoprenaline-induced tremor: evidence for a central origin of essential tremor.
Topics: Adult; Aged; Blood Pressure; Central Nervous System; Female; Heart Rate; Humans; Isoproterenol; Male | 1985 |